If a person's cell have the antigen, the antibody should NOT be present in that person's serum. If an antibody to a blood group antigen is present in the serum of a person, his or her cells should lack that antigen. The antigens are on the cells and the antibodies are in the serum.
Therapy-related myeloid leukemia (t-MDS/t-AML) is a well-recognized clinical syndrome occurring as a late complication following cytotoxic therapy.1â5 The term âtherapy-relatedâ leukemia is descriptive and based on a patientâs history of exposure to cytotoxic agents.
Instead, the disease is described as untreated, in remission or recurrent. that have not been treated. Adult AML in remission refers to cases that have been treated and no longer show signs or symptoms of leukemia in the body. The end stage of the cancer occurs during recurrent AML. There is no typical treatment regimen for individuals with recurrent adult AML, notes the National Cancer Institute.